Skip to content
10-Q

Quarterly Report

NUNZIA PHARMACEUTICAL COMPANY

0001683168-22-007586

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 14, 2022 434.51M sh
Stock Issued Q3 2022 · Sep 30, 2022 270K sh
Shares Diluted Q3 2022 · Sep 30, 2022 434.44M sh
Shares Diluted Q3 2022 · Sep 30, 2022 434.24M sh
Shares Diluted Q3 2022 · Sep 30, 2021 292.77M sh
Shares Diluted Q3 2022 · Sep 30, 2021 290.89M sh
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$190.66K
Stockholders Equity Q3 2022 · Sep 30, 2022 −$191.32K
Stockholders Equity Q3 2022 · Jun 30, 2022 −$117.41K
Stockholders Equity Q3 2022 · Mar 31, 2022 −$132.3K
Stockholders Equity Q3 2022 · Dec 31, 2021 −$94.17K
Stockholders Equity Q3 2022 · Jun 30, 2021 −$80.48K
Stockholders Equity Q3 2022 · Mar 31, 2021 −$78.85K
Current Liabilities Q3 2022 · Sep 30, 2022 $226.69K
Current Liabilities Q3 2022 · Dec 31, 2021 $99.31K
Total Liabilities Q3 2022 · Sep 30, 2022 $226.69K
Total Liabilities Q3 2022 · Dec 31, 2021 $99.31K
Total Assets Q3 2022 · Sep 30, 2022 $35.37K
Total Assets Q3 2022 · Dec 31, 2021 $5.13K
Eps Diluted Q3 2022 · Sep 30, 2022 $0.00
Eps Diluted Q3 2022 · Sep 30, 2022 $0.04
Eps Diluted Q3 2022 · Sep 30, 2021 $0.00
Eps Diluted Q3 2022 · Sep 30, 2021 $0.00
Eps Basic Q3 2022 · Sep 30, 2022 $0.00
Eps Basic Q3 2022 · Sep 30, 2022 $0.04
Sga Expense Q3 2022 · Sep 30, 2022 $211.42K
Sga Expense Q3 2022 · Sep 30, 2022 $249.9K
Net Income Q3 2022 · Sep 30, 2022 −$236.42K
Net Income Q3 2022 · Sep 30, 2022 −$18.98M
Net Income Q3 2022 · Jun 30, 2022 −$20.1K
Net Income Q3 2022 · Mar 31, 2022 −$18.72M
Operating Income Q3 2022 · Sep 30, 2022 −$227.43K
Operating Income Q3 2022 · Sep 30, 2022 −$18.97M
Revenue Q3 2022 · Sep 30, 2022 $0
Revenue Q3 2022 · Sep 30, 2022 $0